Restaurant chain CKE sees IPO at $14-$16/share

Mon Jul 30, 2012 4:39pm IST

Stocks

   

* Sees IPO of 13.3 mln shares

* Co to offer 6.6 mln shares, rest by major shareholder

* To list shares on NYSE under ticker "CK"

July 30 (Reuters) - Private equity-backed CKE Inc, which operates the Carl's Jr and Hardees fast-food chains, expects to sell 13.3 million shares in its initial public offering at between $14 and $16 each.

The company, which intends to list its shares on the New York Stock Exchange under the symbol "CK", will offer half of the shares in the offering, with the rest being sold by major shareholder Apollo CKE Holdings LP, CKE said in a regulatory filing.

CKE, which was taken private by Apollo Management in a nearly $700 million deal in 2010, said last Monday it planned to raise as much as $230 million, up from $100 million it had indicated in May.

Morgan Stanley, Citigroup and Goldman Sachs are lead underwriters of the offering.

A number of private equity-backed restaurant offerings are on the IPO radar as they hope to tap investor demand for specialty regional chains.

Bain Capital-backed Bloomin' Brands -- the parent company of Outback Steakhouse -- is expected to list its shares on the Nasdaq next week.

Monetary Policy Committee

Reuters Showcase

Microfinance

Microfinance

Funding the unfunded: India helps small business borrow to grow  Full Article 

Insurance Sector

Insurance Sector

UK healthcare firm Bupa sees strong growth in India  Full Article 

Sensex Rises

Sensex Rises

Sensex edges up; consumer and healthcare stocks rise  Full Article 

Market Eye

Market Eye

FTSE adds nine Indian firms as large-caps in Asia-Pacific ex-Japan index   Full Article 

Indian Ocean Diplomacy

Indian Ocean Diplomacy

PM Modi to ramp up help for Indian Ocean nations to counter China influence  Full Article 

ECB Bond-Buying

ECB Bond-Buying

ECB raises growth forecasts, to start printing money next week  Full Article 

China Economy

China Economy

China signals "new normal" with lower annual growth target  Full Article 

Pharma Sector

Pharma Sector

Panel recommends waiving late-stage trials for some drugs  Full Article 

E-commerce

E-commerce

China backs e-commerce expansion in win for Alibaba, JD.com  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device  Full Coverage